Short- and intermediate-term improvement of patient quality of life after transcatheter aortic valve implantation: a single-centre study

Abstract

Background: Transcatheter aortic valve implantation (TAVI) is a treatment option for elderly high-risk patients with symptomatic severe aortic stenosis. Improvement of quality of life (QoL) is a relevant issue in this group of patients.

Aim: To assess changes in QoL after TAVI.

Methods: Forty patients who underwent TAVI in our institution were included in this QoL study. All subjects were screened for TAVI in a standard fashion, including QoL assessment with the EQoL (EQ-5D-3L). The pre- and postprocedural scores obtained up to a 12-month follow-up were assessed.

Results: Median of logistic EuroScore I was 21.5% (13.5–26.75%), and Society of Thoracic Surgeons score was 5.5% (4.0–10.75%). Comparison of baseline values with follow-up data at one, six and 12 months after TAVI showed significant improvement of QoL (p < 0.001). Visual Analogue Scale score (VAS score) was assessed. There was an incremental increase in VAS score during follow-up (p < 0.001). Median of six-minute walk test distance at baseline was 200 m (IQR 150–300) and 325 m (IQR 250–400) 12 months after TAVI (p < 0.001).

Conclusions: TAVI provides improved QoL and effectively relieves symptoms.